Medplus Health Services Reports Strong Q3 FY24-25 Growth Amid Financial Challenges
Medplus Health Services has recently adjusted its evaluation, reflecting a strong financial performance in Q3 FY24-25, with net sales growing by 19.81% and net profit increasing by 18.53%. Key metrics indicate a solid market position, though challenges remain, including a low average ROCE and a significant portion of pledged shares.
Medplus Health Services, a midcap player in the retailing sector, has recently undergone an evaluation adjustment reflecting its financial standing. The company reported a very positive performance for the third quarter of FY24-25, showcasing a notable annual growth rate in net sales of 19.81%. Additionally, the operating profit remained stable, while net profit increased by 18.53%, contributing to the overall positive results declared in December 2024.Key financial metrics indicate a strong market position, with the Return on Capital Employed (ROCE) reaching its highest at 8.14% and an impressive inventory turnover ratio of 4.47 times. The operating profit to interest ratio also stood out at 5.10 times, suggesting effective management of operational costs relative to interest obligations.
Despite these strengths, the company faces challenges, including a low average ROCE of 5.19% and a weak EBIT to interest ratio of 1.74, which may impact its ability to service debt. Furthermore, a significant portion of promoter shares, 55.2%, is pledged, which could exert pressure in volatile market conditions.
For those interested in tracking Medplus Health Services' evolving financial landscape, further insights can be found here: Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
